This site uses cookies. By using this site you agree to receiving cookies. View Policy.

60%

Praxonomy aims to become the go-to collaboration platform for boards of pre-IPO, small-cap and mid-cap listed companies as well as regulated private businesses. With more than US$5.5M raised so far, Praxonomy’s easy to use and secure technology has been designed to transform how modern boards work and make decisions.

  • US$5.5M raised so far with a ready-to-scale and highly secure platform
  • $3.3bn market growing at 17% per year
  • COVID has accelerated digital adoption for boards of directors
  • Same team founded AIM-listed NetDimensions and exited for almost £54M
Information £30,000 of funds on the progress bar represent funds raised by the Company, These funds have already been received and shares have been issued. Completion of the Crowdcube raise will occur on the same material terms and share price.

Idea

Praxonomy aims to modernise the way boards work. Boardlogic, our cloud portal, is an encrypted collaboration platform purpose-built for boards and governing bodies. With a focus on ease of use, practicality, privacy and data security, Boardlogic is designed to take the sting out of digital transitions and help cut meeting-related time and costs.

Our client list includes the FT Board Director Programme, ACOLIN, St George's University of London and Habitat for Humanity HK. We’ve established high-value channels with, among others, the London Stock Exchange Group Issuer Services Marketplace and the Crown Commercial Service G-Cloud.

The estimated $3bn board portal market is expected to grow at 17% per year and reach $12bn by 2029. Given that EY recently reported that 81% of boards cite increasing cyber threats as highly relevant we expect that strengthening cybersecurity will be a key growth driver for Praxonomy.

With more than US$5.5M already invested, in large part for product development, Praxonomy has positioned Boardlogic as an enterprise-grade, production-proven product for a growing market sector. Praxonomy itself is VeraSafe Privacy Seal certified, GDPR compliant and ISO27001 security audit certified.

The funds we raise on Crowdcube will help us grow the company, invest in product innovations and expand our sales and marketing capabilities, especially in the UK and EU.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Praxonomy pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

This pitch is approved by Crowdcube

This pitch is approved as a financial promotion by Crowdcube Capital Limited. Every pitch on Crowdcube is reviewed to ensure it is fair, clear and not misleading.

As part of our commitment to investor transparency, Crowdcube’s Due Diligence Charter outlines the analysis and verification that is conducted on equity fundraises on Crowdcube by our legal and compliance professionals.

Read more

Risk warning

Investing in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. You will only be able to invest via Crowdcube once you are registered as sufficiently sophisticated. Please click here to read the full Risk Warning.

Crowdcube is authorised and regulated by the Financial Conduct Authority (FCA) and the Comisión Nacional del Mercado de Valores (CNMV). This page has been approved by Crowdcube. Pitches for investment are not offers to the public and investments can only be made by members of crowdcube.com on the basis of information provided in the pitches by the companies concerned. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Praxonomy has submitted their plans to raise money, details of their structure and trade etc. to HMRC and is awaiting advice on whether the share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax reliefs.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.